SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-19-000274
Filing Date
2019-01-17
Accepted
2019-01-17 11:53:23
Documents
1
Group Members
EMPERY ASSET MASTER, LTD.EMPERY TAX EFFICIENT II, LPMARTIN D. HOERYAN M. LANE

Document Format Files

Seq Description Document Type Size
1 SELLAS LIFE SCIENCES GROUP, INC. p19-0094sc13ga.htm SC 13G/A 73850
  Complete submission text file 0000902664-19-000274.txt   75807
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Subject) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-84090 | Film No.: 19530482
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020 212-608-3300
Empery Asset Management, LP (Filed by) CIK: 0001469336 (see all company filings)

IRS No.: 262107121 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A